FLGT - Fulgent Genetics, Inc.

QQQ $ 611.79 $ 0.27 (0.04 %)

DIA $ 469.67 $ 2.55 (0.55 %)

SPY $ 671.83 $ 0.34 (0.05 %)

TLT $ 92.00 $ 0.01 (0.01 %)

GLD $ 378.12 $ -8.52 (-2.2 %)

Previous Close

$ 23.84

Open

$ 24.07

Bid

$ 23.93 x 8

Ask

$ 23.96 x 30

Day's Range

$ 23.70 - $ 24.60

52 Week Range

$ 14.57 - $ 24.30

Volume

306,596

Average Volume

Market Cap

729.72M

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2025	06-30-2025	10-Q
2	05-02-2025	03-31-2025	10-Q
3	02-28-2025	01-01-1970	10-K
4	11-08-2024	09-30-2024	10-Q
5	08-02-2024	06-30-2024	10-Q
6	05-03-2024	03-31-2024	10-Q
7	02-28-2024	12-31-2023	10-K
8	11-03-2023	09-30-2023	10-Q
9	08-04-2023	06-30-2023	10-Q
10	05-05-2023	03-31-2023	10-Q
11	02-28-2023	12-31-2022	10-K
12	11-07-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-09-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-07-2021	03-31-2021	10-Q
19	03-08-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-05-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	03-13-2020	12-31-2019	10-K
24	11-08-2019	09-30-2019	10-Q
25	08-12-2019	06-30-2019	10-Q
26	05-10-2019	03-31-2019	10-Q
27	03-22-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-13-2018	06-30-2018	10-Q
30	05-14-2018	03-31-2018	10-Q
31	03-20-2018	12-31-2017	10-K
32	11-13-2017	09-30-2017	10-Q
33	08-14-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-17-2017	12-31-2016	10-K
36	11-14-2016	09-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Fulgent Genetics Reports Phase 2 Cancer Dr...
10/20/2025 10:11:49

Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-estab...

UBS Upgrades Fulgent Genetics to Buy, Rais...
08/05/2025 11:19:42

UBS analyst Lu Li upgrades Fulgent Genetics (NASDAQ:FLGT) from Neutral to Buy and raises the price target from $20 to $30.

Piper Sandler Maintains Neutral on Fulgent...
08/04/2025 15:56:38

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...

monolithic-power-systems-workiva-interface-appfolio-and-other-big-stocks-moving-higher-on-friday

Monolithic Power Systems, Workiva, Interfa...
08/01/2025 14:44:18

12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Fulgent Genetics Raises FY2025 Adj EPS Gui...
08/01/2025 11:04:01

Fulgent Genetics (NASDAQ:FLGT) raises FY2025 Adj EPS guidance from $(0.65) to $(0.35) vs $(0.55) analyst estimate. Raises FY202...

Fulgent Genetics Q2 Adj. EPS $0.07 Beats $...
08/01/2025 11:01:51

Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $(0....

Earnings Scheduled For August 1, 2025
08/01/2025 08:32:17

Fulgent Genetics Earnings Preview
07/31/2025 17:03:18

Fulgent Genetics Secures EU CE Mark For Fu...
07/17/2025 11:08:06

Piper Sandler Maintains Neutral on Fulgent...
05/06/2025 16:09:57

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and raises the price target f...

Raymond James Reiterates Outperform on Ful...
05/05/2025 13:48:53

Raymond James analyst Andrew Cooper reiterates Fulgent Genetics (NASDAQ:FLGT) with a Outperform and raises the price target ...

Fulgent Genetics Affirms FY2025 GAAP EPS G...
05/02/2025 11:04:18

Fulgent Genetics (NASDAQ:FLGT) affirms FY2025 GAAP EPS guidance from $(1.95) to $(1.95) vs $(1.34) analyst estimate..

Fulgent Genetics Affirms FY2025 Adj EPS Gu...
05/02/2025 11:03:50

Fulgent Genetics (NASDAQ:FLGT) affirms FY2025 Adj EPS guidance from $(0.65) to $(0.65) vs $(0.66) analyst estimate. Affirms FY2...

Fulgent Genetics Q1 Adj. EPS $0.04 Beats $...
05/02/2025 11:01:10

Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0....

Earnings Scheduled For May 2, 2025
05/02/2025 08:32:20

A Peek at Fulgent Genetics's Future Earnings
05/01/2025 18:03:47

Piper Sandler Maintains Neutral on Fulgent...
03/04/2025 16:51:44

Piper Sandler analyst David Westenberg maintains Fulgent Genetics (NASDAQ:FLGT) with a Neutral and lowers the price target f...

Fulgent Genetics Sees FY25 Revenue Of $310...
02/28/2025 12:04:06

Fulgent Genetics Q4 Adj $0.04 Beats $(0.12...
02/28/2025 12:01:52

Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0....